Daniel F. McAuley

Queen's University Belfast — United Kingdom

Medicine · Health Sciences

97h-index56.8kcitations755works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory Support and Mechanisms(265), Intensive Care Unit Cognitive Disorders(169), Sepsis Diagnosis and Treatment(143), Neonatal Respiratory Health Research(93), Cardiac Arrest and Resuscitation(78)

Publications709 total

Biofilm communities above and below the cuff of endotracheal tubes are spatially homogenous
Respiratory Research·2026Open Access
The POETIC (PrOcess Evaluation of Trials In Critical care) Framework: A Structured Approach for Designing and Conducting Process Evaluations in Critical Care Trials
Critical Care Explorations·2025Open Access
Co-enrolment in critical care trials: a secondary analysis of the RECOVERY-RS trial
Critical Care·2025Open Access
Who is responsible for follow-up after critical illness? GP, ICU and patient perspectives
Critical Care·2025Open Access
Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome
Stem Cells Translational Medicine·2025· 1 citedOpen Access
S169 Investigating the effect of baricitinib on neutrophilic inflammation in an ex vivo lung perfusion (EVLP) model of acute respiratory distress syndrome
2025
S4 Effects of hyperoxia on pulmonary inflammation and organ injury in a human <i>in vivo</i> model (HIPI): a randomised, double-blind, placebo-controlled trial
2025· 1 cited
Safety and efficacy of inhaled PEG-ADM in ARDS patients: a randomised controlled trial
Critical Care·2025Open Access
Greater recovery after critical illness (GRACE): a call to action to create a new roadmap for critical illness research
Thorax·2025· 1 citedOpen Access
Development of a patient centred, structured, individually tailored, multi-component intervention to promote rehabilitation and recovery after critical illness: content, theory, and construction.
NIHR Open Research·2025Open Access
Hypertonic Saline or Carbocisteine in Bronchiectasis
New England Journal of Medicine·2025· 8 citedOpen Access
Effectiveness of mucoactives compared to standard care in adult bronchiectasis: A systematic review
2025
Adjudication of pulmonary exacerbations in bronchiectasis using the EMBARC consensus exacerbation criteria: data from the CLEAR Trial
2025
Views of consent approaches used in emergency and critical care research: an ERS Clinical Research Collaboration rapid, systematic review of the acceptability of alternative consent models
2025
RCT Abstract - Effectiveness of hypertonic saline (HTS 6%) and carbocisteine in reducing bronchiectasis exacerbations (Results of the CLEAR randomised trial)
2025
Public perceptions of participation in trials in the intensive care unit: an ERS Clinical Research Collaboration international cross-sectional survey across 13 countries
2025
Bedside prospective identification of ARDS subphenotypes: a multicentre study - an ERS Clinical Research Collaboration
2025
Drug response assessment trials for inhaled hypertonic saline in patients with bronchiectasis: Analysis of data from the CLEAR trial
2025
Bradykinin inhibition in COVID-19: a randomised, double-blind trial of icatibant versus placebo
2025
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials
Thrombosis Research·2025
page 1 of 36Next →

Frequent Co-authors

Cecilia O’Kane(15), Michael A. Matthay(11), John G. Laffey(10), Gavin D. Perkins(10), Carolyn S. Calfee(10), Manu Shankar‐Hari(9), Eddy Fan(7), Bruce Thompson(7), Anthony Gordon(7), Charlotte Summers(7), Laurent Brochard(6), J. Kenneth Baillie(6), Alistair Nichol(6), Timothy Walsh(6), Luciano Gattinoni(5), Arthur S. Slutsky(5), Antonio Pesenti(5), Kevin Delucchi(5), Pratik Sinha(5), David M. Maslove(5)